Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Outsourcing channel feed
CPhI: As pandemic reaches its final stages, an industry busier than ever reflects on lessons learned
4 years ago
Manufacturing
Catalent wraps up San Diego site buildout as it continues to make waves with global acquisitions
4 years ago
Manufacturing
Charles River Laboratories has been on an acquisition spree. But Tuesday, it offloaded two assets
4 years ago
Deals
New England-based distributor HPNE looks to double its workforce to keep up with demand
4 years ago
Manufacturing
Estate of Henrietta Lacks sues Thermo Fisher over the improper sale of her immortal cells
4 years ago
Cell/Gene Tx
FDA calls for repeat bioequivalence studies after uncovering 'invalid' data from two Indian CROs
4 years ago
FDA+
Contract research is having a moment right now. Will M&A splashes drive the industry to even greater heights?
4 years ago
In Focus
Catalent inks deal with Phathom to make GI drug at recently-renovated Kentucky site
4 years ago
Manufacturing
BioDuro-Sundia plants its flag at former Par manufacturing site in CA
4 years ago
Manufacturing
As leader is freed from prison, Samsung Biologics nabs massive investment from parent company's $205B spending spree
4 years ago
Manufacturing
Verily scoops up a fellow software maker as Amy Abernethy scales its clinical trials platform
4 years ago
Deals
Abcam brings a longtime collaborator in house as part of $340M buyout pact
4 years ago
Deals
Shelling out $5B+, PerkinElmer pays the big bucks for antibody and reagent player
4 years ago
Deals
Recipharm to construct new Indian fill-finish facility as part of existing relationship with Nichepharm founding family'
4 years ago
Manufacturing
Catalent keeps adding on at key Italian plant, this time with a pair of new bioreactors and 100 jobs
4 years ago
Manufacturing
Catalent lands 2 new partnerships, including for glioblastoma drug; US drops $153M into pandemic preparedness
4 years ago
Manufacturing
Already sitting on a major stem cell bank, Generate looks to grow its regenerative medicines business
4 years ago
Manufacturing
A couple months after landing $100 million in funding, Cellares grabs partner for its Cell Shuttle
4 years ago
Manufacturing
Moroccan government drops $500M into new Recipharm fill-finish plant in big boost for African manufacturing
4 years ago
Manufacturing
FDA hands a warning letter to a Lupin subsidiary after failing to maintain cleanliness once again
4 years ago
Manufacturing
Evotec expands presence in Italy with acquisition of former GlaxoSmithKline R&D site
4 years ago
R&D
Years after bankruptcy, Dendreon adds a contract manufacturing wing
4 years ago
Manufacturing
WuXi will add 500 jobs at Delaware manufacturing campus as it looks to bolster its CDMO arm
4 years ago
Manufacturing
Catalent bags a German stem cell developer to build its next-gen therapeutics wing
4 years ago
R&D
Manufacturing
First page
Previous page
1
2
3
4
5
6
Next page
Last page